C-QIYPCalico
aging biology, systems biology, drug development
discoverydiscoveringsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-QIYP
C-QIYPC-QIYPaging biology, systems biology, drug development
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Сентябрь 2009 года, Стэнфордская лаборатория, два часа ночи. Аспирант Томас Рэндо смотрит под микроскоп и видит то, чего в биологии быть не должно: ткани старой мыши начали омолаживаться. Эксперимент, который его научный руководитель назвал академическим самоубийством, сработал — и разрушил всё, что было написано в учебниках о старении. В этом видео мы расскажем о самой большой научной революции нашего времени: о том, как биологи перестали считать старение неизбежным законом природы и начали говорить о нём как о болезни. О пределе Хейфлика — открытии 1961 года, доказавшем, что в наши клетки встроен счётчик. О теломерах и митохондриях. О девяти признаках старения, которые запускаются у всех людей одновременно после сорока лет. Вы узнаете о Жанне Кальман — единственном человеке в истории, прожившем 122 года и 164 дня. О гренландской акуле, которая родилась во времена Тридцатилетней войны и до сих пор плавает в холодных водах Северной Атлантики. О голом землекопе, который живёт 30 лет и
Jeff Bezos finance secrètement la jeunesse éternelle. Devine pourquoi. Tout commence en 2013. Google crée Calico, une filiale dédiée à la longévité. À sa tête, Arthur Levinson, l’ex-PDG de Genentech. L’objectif : comprendre les mécanismes du vieillissement pour les ralentir, voire les inverser. Budget estimé : plus d’un milliard de dollars. Mais 10 ans plus tard, peu de publications, et encore moins de traitements concrets. En 2022, le vent tourne. Une nouvelle startup attire tous les regards : Altos Labs. Cofinancée par Jeff Bezos, elle lève discrètement 3 milliards de dollars. Sa promesse ? Reprogrammer les cellules pour leur redonner un âge biologique plus jeune. Ces projets ne sont pas seuls. Peter Thiel, le cofondateur de PayPal, finance la Methuselah Foundation. Sam Altman d’OpenAI injecte 180 millions dans Retro Biosciences. Même Vitalik Buterin, fondateur d’Ethereum, milite pour considérer le vieillissement comme une “faille système” à corriger. Ce que tous ces hommes ont e
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that causes fluid-filled cysts to develop in the kidneys. The purpose of this study is to assess the safety and efficacy of ABBV-CLS-628 for the treatment of ADPKD in adult participants. ABBV-CLS-628 is an investigational drug being developed for the treatment of ADPKD. Participants are placed in 1 of 4 groups, called treatment arms. Each group receives a different treatment. There is a 1 in 4 chance that participants will be assigned to placebo. Around 240 adult participants with ADPKD will be enrolled at approximately 100 sites worldwide. Participants will receive IntraVenous ABBV-CLS-628 or placebo every 4 weeks for 92 weeks. Participants will be followed for up to 15 weeks. There may be higher treatment burden for participants in this trial compared to their standard of care . Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Arthur D. Levinson – 4,359,576 – 0.028% Contrary to common belief, Tim Cook, Apple’s CEO, is not the company’s largest individual shareholder. Arthur Levinson is Apple’s largest individual shareholder, owning 4.35 million shares as of May 30, 2024. His stake accounts for only 0.028% of Apple’s total outstanding stock. Levinson chairs Apple’s board and is also the co-founder and CEO of Calico, an Alphabet Inc. subsidiary. He previously served as a director at Google and as CEO of Genentech. --- If you liked this post: ❤️ Like | 🗣️ Comment | 💾 Save | 🌎 Share Thank you. This is not an advertisement, a sales offer, or a solicitation for an investment in any entity or other investment vehicle. The information provided here is not intended to be used as investment advice or as a source of specific investment recommendations, nor does it provide implicit or explicit recommendations on the suitability of an investment for a particular investor. This content is for educational purposes
The purpose of this study is to evaluate mass balance, pharmacokinetics and safety of \[14C\] ABBV-CLS-7262 in healthy, male volunteers following administration of a single oral dose.
This is a randomized, blinded, placebo and active-controlled, 4-period, crossover design thorough QT/QTc (TQT) study to evaluate the effect of ABBV-CLS-7262 on cardiac repolarization in healthy adult subjects.
This study is a randomized, three period, six sequence, single dose crossover design with ABBV-CLS-7262 in healthy adult subjects.
#cat #trending #viral #video #cute #funny #cats #catvideos ##catmusic #shorts #short #whatsappstatus #quotes #edit #explore #reels #tiktok #trendingshorts #youtubeshorts #youtube #ytshorts #youtuber #update #india #instagram #omletarcade #pubgmobile #pubg #pakistan #art #anime #attitude #shortvideo #subscribe #dance #freefire #gaming #gameplay #hindi #jokes #kids #love #like #live #livestream #zodiac #zoo #xbox #comedy #cricket #viralshorts #viralvideo #breakingnews #nature #new #music #memes #motivation #vlog cats and dogs, cats and dogs funny videos, cats and dogs movie, cats and dogs full movie, cats and dogs funny videos 2023, cats and dogs 2001, cats and dogs the revenge of kitty galore, cats and dogs trailer, cats and dogs fighting, cats and dogs funny, cats and dogs videos, cats and dogs are funny, cats and dogs ancient egypt, cats and dogs are fighting, cats and dogs agent dogs, cats and dogs as friends, cats and dogs alternate ending, cats and dogs animation, cats and dogs
This study follows an open-label, single arm design with two periods with rosuvastatin, digoxin and ABBV-CLS-7262
Fosigotifator is an investigational drug being researched for the treatment of Vanishing White Matter disease in adult, pediatric and infant participants. This is a 201-week, open-label, multiple cohort study enrolling adults, pediatric and infant participants with Vanishing White Matter disease. Participants will attend regular visits during the course of the study and complete medical assessments, blood tests, questionnaires, and be evaluated for side effects.
Art Levinson is the CEO of Calico (a company funded by Google to develop new medicines for aging) as well as the Chairman for Apple, and he was CEO of Genentech from 1995 to 2009. In 15 years, Art went from a scientist to CEO of Genentech, which was his first job after doing a postdoc at UCSF. His tenure was characterized by increasing the company’s focus, preserving its science-first culture, and leading the approval for a string of transformative medicines from Herceptin to Avastin. https://axialobservations.substack.com/p/eight-lessons-from-art-levinson-genentechcalico #biotechnology #science #vc #startup #startups #startupideas #biology #biotech #chemistry #business #speech #speeches #investing #investment #lifescience #casestudy #scientist #scientists #inventors #inventor #inventions #invention #research #innovation #siliconvalley #entrepreneur #entrepreneurship #entrepreneurs #healthcare #genomics #genetics #history #biologia #technology #tech #founderstories #founder #founders
Diya Kids Toys :Vlad and Nikita Playing Toys. Diya videos for kids. Diya Toys Car for Kids video toys ,dolls,fidget toys,lego star wars,lol surprise,bakugan,lol dolls,buzz lightyear polly pocket,lego harry potter,smyth toys,remote control carmr potato head,barbie dream house fidget,furby,fidget spinner,play doh,pop it fidget toy,sylvanian familiesreborn,mini brands toyhouse,paw patrol toys,hatchimals,rc cars,orbeez,lego batman,ryan's world,doll house doc mcstuffins,smith toys,care bears,barbies,rainbow high dolls,bratz dolls,fidget cube power rangers beast morphers,barbie dreamhouse adventures,stress ball,thomas the train nerf fortnite,roblox toys,squishies,fidget pack,pogo stick,goo jit zu,beyblades inflatable pool,dinosaur toys,funko pops,car toys,lucy doll,lego millennium falcon learning express near me,barbie extra,toy car,gabby's dollhouse,calico critters remote control helicopter,.slinky,tonka,omg dolls,barbie camper,toy store near me hot wheels track,robocar poli,plushies,rebor
2021 Benjamin Franklin Awards Bower Award for Business winner, Dr. Arthur D. Levinson, is honored for his innovative leadership building Genentech into a global biotechnology pioneer, his strategic guidance of Apple, and his commitment to advancing human health and longevity at Calico—a distinguished career that exemplifies the spirit of scientific inquiry and entrepreneurship embodied by Benjamin Franklin. Learn more at fi.edu/awards
Biochemist and business leader Art Levinson is chairman of Apple and co-founder & CEO of Calico, with a mission to promote human longevity with biotech solutions to treat the health effects of aging! We are excited to honor Art with the Bower Award for Business Leadership during our Awards Ceremony on April 29th. Learn more at fi.edu/awards.
The study will assess the safety, PK, PD, and preliminary efficacy of ABBV-CLS-484 as monotherapy and in combination with a PD-1 targeting agent or with a or a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI). The trial aims to establish a safe, tolerable, and efficacious dose of ABBV-CLS-484 as monotherapy and in combination. The study will be conducted in three parts. Part 1 Monotherapy Dose Escalation, Part 2 Combination Dose Escalation and Part 3 Dose Expansion (Monotherapy and Combination therapy). Part 1, ABBV-CLS-484 will be administered alone in escalating dose levels to eligible subjects who have advanced solid tumors. Part 2, ABBV-CLS-484 will be administered at escalating dose levels in combination with a PD-1 targeting agent or with a VEGFR TKI to eligible subjects who have advanced solid tumors. Part 3, ABBV-CLS-484 will be administered alone as a monotherapy at the determined recommended dose in subjects with locally advanced or metastatic, relapsed or refractory head and neck squamous cell carcinoma (HNSCC), relapsed or refractory non-small cell lung cancer (NSCLC), and advanced clear cell renal cell carcinoma (ccRCC). ABBV-CLS-484 will also be administered at the determined recommended dose in combination with a PD-1 targeting or with a VEGFR TKI agent in subjects with locally advanced or metastatic, HNSCC, NSCLC, MSI-H tumors refractory to PD-1/PD-L1, and advanced ccRCC.
2020, the year of, well, let's just go with connection shall we? It's a year that has made us think outside of the box and invent new ways to come together and to celebrate. Take this couple for example, they managed to merge their kiwi wedding with their far off loved ones in perfect synchrony. Two sides of the globe coming together to celebrate one union. And what a union it is! Lizi and Gurmeet, I couldn't have been more stoked to be there for your big day in Wanaka. What a way to kick off the season. Here's to love, here's to friends, and here's to you. 🎼 Ja Ja Ding Dong! 🎼 Celebrant // Gwen Hendry Photographer // Simon Darby Ceremony & Reception // Glendhu Station Sound // Entertainment Solutions (Grenville Craig) Helicopter // Aspiring Helicopters Catering // Raspberry Creek Band // Calico Floral arrangements & bouquets // Studio24 Hair // Absolutely Fabulous Hair (Sara Bollati) Makeup // Janine Joseph Wedding Dress // Bride and Winter Groomsmen Suits // Rembrandt Rings // Bl
Who owns the most shares of Apple? Who Are the Largest Shareholders of Apple? (AAPL) - Investopedia Feb 11, 2019 Arthur Levinson is the chairman of the board of Apple, the current CEO of Calico, and the single-largest individual shareholder with 1.1 million shares as of Aug. 3, 2018.
Arthur Levinson, founder and CEO of Calico- National Medal of Technology and Innovation for his contributions to the fields of biotechnology and personalized medicine. He is also the chairman of the board of Apple. Levinson's research with Genetech led to the development of a Herceptin, a drug which combats HER2+ cancer. LINKS: http://www.evolvingcom.com/ https://www.facebook.com/evolvingcommunications https://www.linkedin.com/company/evolving-communications https://vimeo.com/evolvingcommunications
Arthur D. Levinson Calico For pioneering contributions to the fields of biotechnology and personalized medicine, leading to the discovery and development of novel therapeutics for the treatment of cancer and other life-threatening diseases. Produced by Evolving Communications for the National Science & Technology Medals Foundation with support from Genentech.
Video courtesy The White House. See the complete video and all of the awardees at: https://www.youtube.com/watch?v=NYOonZ5e7F0 President Barack Obama presented the National Medal of Technology and Innovation to Carnegie Mellon University’s Mary Shaw (CS'72), citing her innovations to computer science education, during a White House ceremony Nov. 20. Shaw, who earned her Ph.D. in computer science at CMU, is the Alan J. Perlis University Professor of Computer Science in the Institute for Software Research. She was honored along with 18 other recipients of the National Medal of Science and the National Medal of Technology and Innovation. “The story of these trailblazers reflect our bigger American story of constant transformation,” President Obama said. “They represent the spirit that has always defined the American people, one of restless searching for the right solution to any problem; an inclination to dream big dreams; and an insistence on making those dreams come true.” The pre
Future of Humanity Institute: www.fhi.ox.ac.uk - Also see other recent interviews on Google's Anti-Aging initiative: - Ben Goertzel: https://www.youtube.com/watch?v=dtkjWijmR4M - Aubrey de Grey: http://www.youtube.com/watch?v=1_Cr3XeVk7k - Christine Peterson: http://www.youtube.com/watch?v=KYpSYGarWkY - Karl Hale: http://www.youtube.com/watch?v=SojxtW-r-dM - James Hughes: http://www.youtube.com/watch?v=7zp5bXfVcNs - Anders Sandberg: http://youtu.be/v9Z8qNCOc0Q - George Dvorsky: http://www.youtube.com/watch?v=Gddz-o5T1Kc - David Orban: http://www.youtube.com/watch?v=Kip8563BUw8 - David Pearce: pt1 http://www.youtube.com/watch?v=HQm9JsCP7VU - pt2 http://www.youtube.com/watch?v=Gx3yNk4XUNY Google's Calico Announcement: https://plus.google.com/+LarryPage/posts/Lh8SKC6sED1 In today's TIME Tech Exclusive Google vs. Death, Larry Page announced Calico, a new Google firm focusing on the challenges of healthcare, aging and associated diseases. "Illness and aging affect all our famil
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-CLS-484 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.